The world’s newest anti-viral treatment for COVID-19, Sotrovimab, is now available for early treatment of certain categories COVID-19 patients in the UAE following a landmark agreement between the Abu Dhabi Department of Health, Rafed, and ...
Rafed, a healthcare group purchasing organisation that is part of ADQ has signed an agreement with G42 Healthcare, a healthcare technology company, and a subsidiary of Abu Dhabi-based Group 42, to provide advanced services that ...